US-based Genocea Biosciences has raised an approximate net value of $61.4m from selling 5.5 millions shares of common stock at a price of $12 per share in an initial public offering.
Month: March 2014
IPO injection for Flexion
Flexion Therapeutics, a US-based biotechnology company currently advancing a portfolio of injectable analgesic drug candidates, has sold 5.750 million shares of common stock in their initial public offering (IPO). The shares were offered at a price of $13 per share for an initial market cap of around $192m. BMO Capital Markets and Wells Fargo Securities… Continue reading IPO injection for Flexion
$103.5m for Dicerna Pharmaceuticals
US-based biopharmaceutical company Dicerna Pharmaceuticals has closed their initial public offering selling 6.9 million shares of common stock.
Chukong seeks $150m high score
Chinese mobile game developer Chukong Technologies is preparing a $150m US initial public offering.
$19m for Biocept in IPO
Molecular oncology diagnostics company Biocept has raised $19m in their initial public offering by selling 1.9 million shares of common stock.
LED lighting company Glo closes $30m series D round
The Sweden-based company, which uses nanotechnology to develop next-generation lighting products, counts Agder Energi Ventures among its existing investors.
BlueCross Blue Shield co-leads $6m AbilTo series B
The therapeutic programme provider has now raised $9m after completing a series B round that also included Sandbox Industries and existing investor .406 Ventures.
Percolate brews up $24m as WPP joins investors
The marketing software developer has raised $24m in a round led by Sequoia Capital and supported by WPP, which takes the company’s total fundraising to $34.5m since it was formed.
Cisco and WWE opt for a bit of Phunware
Phunware, developer of a platform that allows brands to engage with their customers on mobile devices, has secured $30m and WWE and Cisco are among the investors.
Alder Biopharmaceuticals seeks to avoid headache as it files for $115m IPO
Alder, which is developing antibodies to fight migraine and arthritis, secured $38m in a 2012 venture round backed by Novo and TPG, and will use the money from the initial public offering to forward testing.
Xilinx speeds into $16m Aquantia series G
Ethernet technology company Aquantia has now raised $154m since it was founded, and counts corporates Xilinx and LSI as backers.
Lockheed Martin secures ABB’s stake in Industrial Defender
ABB Technology Ventures made a profitable exit as it sold its share of cyber security company Industrial Defender to Lockheed Martin, which has fully acquired the business.
Meican gives Nokia the munchies
Nokia Growth Partners, alongside existing investor Kleiner Perkins Caufield & Byers, has invested $10m in a series B round of funding raised by China-based online food ordering company Meican. Food-delivery companies are growing in popularity across Asia, especially in China, as the number of internet users increases and a burgeoning middle class with disposable income turns to ordering food online.
Byecity takes off with Alibaba
Byecity, a Chinese website providing travel and tourism information, has raised approximately $20m in a series B round of funding provided by Alibaba Capital Partners and CBC capital.